P
Picard Medical, Inc. (PMI)
ASE – Real Time Price. Currency in USD
0.18
-0.02 (-12.14%)
At close: May 12, 2026, 4:00 PM EDT
0.18
-0.00 (-0.56%)
Pre-market: May 13, 2026, 4:12 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
0.18
-0.02 (-12.14%)
At close: May 12, 2026, 4:00 PM EDT
0.18
-0.00 (-0.56%)
Pre-market: May 13, 2026, 4:12 AM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.11 | 3.40 | 7.0 | |
| Quick ratio | 0.72 | 2.52 | 4.0 | |
| Debt to Equity | 1.84 | 1.11 | 3.0 | |
| Debt to Assets | 0.31 | 1.58 | 7.0 | |
| Interest coverage | -1.31 | 4.33 | 1.0 | |
| Weighted average score | 4.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 4M | 5M | 4M | 5M | 5M |
| Gross Profit | -5M | -3M | -112K | -253K | -242K |
| Operating Income | -11M | -16M | -14M | -13M | -13M |
| Net Income | -11M | -16M | -21M | -27M | -27M |
| EBITDA | -11M | -15M | -13M | -13M | -13M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -14.99 | 58.84 | N/A | 32.81 | 5.5 |
| Y/Y | 20.69 | 51.45 | N/A | -38.85 | 5.5 |
| 3y average | 7.4 | -34.28 | N/A | -14.17 | 2.0 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 3.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $11.5M significantly exceed its total debt $7.0M, ensuring strong financial flexibility
Total current assets $20.7M exceed Total current liabilities $18.7M, highlighting excellent liquidity
Debt-to-equity ratio (1.8) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-1.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.4M limits the company's ability to reinvest or pay down debt